← Eichor
Study identifier: NCT07258563 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The TASTY-steering Study

Condition: Metastatic Triple Negative Breast Cancer · Metastatic Testicular Cancer · Stage II-IV Diffuse Large B Cell Lymphoma  ·  Sponsor: University Medical Center Groningen

PhaseNA
Planned participants201
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

This is a multicentre non-blinded randomised intervention trial with a parallel cluster design. The multicentre study will be performed at 12 hospitals in the Netherlands. A parallel cluster design per hospital was selected to prevent contact between participants in the same hospital who are randomised into different study arms. Such contact may result in bias as it may allow for patients in the control arm to be informed about elements of taste steering. To examine the effect of at-home taste steering versus standard care on food enjoyment, the obtained results and outcomes will be measured 1) at baseline before chemotherapy is started, 2) at week 0 when taste or smell alterations occur, and 3) after 6 weeks. The taste steering will take place at home. The control group will receive usual care. Questionnaires will be filled in online at home, while taste and smell tests and saliva collection will be conducted either at home or in the hospital during regular visits. Patients in both study arms are contacted by their dietitian every 3 weeks. Some hospitals have implemented elements of taste steering. However, these elements are focused on patients who are admitted to the hospital, and therefore only interfere to a limited extent with the present study that is directed at patients managing their taste alterations at home. Experience with the Smaakpupil tool indicates that the algorithm reaches saturation after 3-4 weeks. Therefore, an intervention period of 6 weeks has been s…

This description comes directly from the study's public registry record.

Talk to the study team

J. J. de Haan, MD, PhD  ·  +31 50 361 2821  ·  j.j.de.haan@umcg.nl

M. D. Douma  ·  +31 50 361 4603  ·  m.d.douma@umcg.nl

Always discuss trial participation with your own doctor first.

Locations (11)

Amsterdam UMCAmsterdam, NetherlandsRecruiting
Rijnstate ZiekenhuisArnhem, NetherlandsNot Yet Recruiting
Van Weel-Bethesda ZiekenhuisDirksland, NetherlandsNot Yet Recruiting
Ziekenhuisvoorzieningen Gelderse ValleiEde, NetherlandsRecruiting
University Medical Center GroningenGroningen, NetherlandsRecruiting
Martini ZiekenhuisGroningen, NetherlandsRecruiting
Radboud University Medical CenterNijmegen, NetherlandsNot Yet Recruiting
Ikazia ZiekenhuisRotterdam, NetherlandsRecruiting
Ommelander Ziekenhuis GroningenScheemda, NetherlandsRecruiting
Maxima Medisch CentrumVeldhoven, NetherlandsNot Yet Recruiting
Isala KliniekenZwolle, NetherlandsNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07258563